Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the STERIS SYSTEM 1 processorSORIN, Mircea; SEGAL-MAURER, Sorana; MARIANO, Noriel et al.Infection control and hospital epidemiology. 2001, Vol 22, Num 7, pp 409-413, issn 0899-823XArticle

Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumanniiAFZAL-SHAH, Mariya; WOODFORD, Neil; LIVERMORE, David M et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 2, pp 583-588, issn 0066-4804Article

Modified hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter speciesLEE, K; CHONG, Y; SHIN, H. B et al.Clinical microbiology and infection. 2001, Vol 7, Num 2, pp 88-91, issn 1198-743XArticle

C-Terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenemEPP, Simone F; KÖHLER, Thilo; PLESIAT, Patrick et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 6, pp 1780-1787, issn 0066-4804Article

PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumanniiBOU, G; CERVERO, G; DOMINGUEZ, M. A et al.Clinical microbiology and infection. 2000, Vol 6, Num 12, pp 635-643, issn 1198-743XArticle

Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumanniiQIANG TAN; OGAWA, Aimie M; RAGHOOBAR, Susan L et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 14, pp 4363-4365, issn 0960-894X, 3 p.Article